Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
IMpower010: A Phase III trial investigating atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy (chemo) in patients (pts) with completely resected NSCLC Zhou, C., Altorki, N., Vallieres, E., Felip, E., Zuo, Y., Howland, M., Xia, F., Hoang, T., Sandler, A., Wakelee, H. OXFORD UNIV PRESS. 2016
View details for Web of Science ID 000393980600427